- Home
- MDGL vs TFX Comparison
MDGL vs TFX Comparison
Compare MDGL & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- TFX
- Stock Information
- Founded
- MDGL 2011
- TFX 1943
- Country
- MDGL United States
- TFX United States
- Employees
- MDGL N/A
- TFX N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- TFX Medical/Dental Instruments
- Sector
- MDGL Health Care
- TFX Health Care
- Exchange
- MDGL Nasdaq
- TFX Nasdaq
- Market Cap
- MDGL 6.8B
- TFX 5.3B
- IPO Year
- MDGL N/A
- TFX N/A
- Fundamental
- Price
- MDGL $275.26
- TFX $122.54
- Analyst Decision
- MDGL Strong Buy
- TFX Hold
- Analyst Count
- MDGL 10
- TFX 10
- Target Price
- MDGL $420.63
- TFX $176.50
- AVG Volume (30 Days)
- MDGL 335.5K
- TFX 495.0K
- Earning Date
- MDGL 05-01-2025
- TFX 05-01-2025
- Dividend Yield
- MDGL N/A
- TFX 1.11%
- EPS Growth
- MDGL N/A
- TFX N/A
- EPS
- MDGL N/A
- TFX 3.20
- Revenue
- MDGL $317,383,000.00
- TFX $3,010,144,000.00
- Revenue This Year
- MDGL $285.43
- TFX $2.88
- Revenue Next Year
- MDGL $63.77
- TFX $4.85
- P/E Ratio
- MDGL N/A
- TFX $38.19
- Revenue Growth
- MDGL N/A
- TFX 0.29
- 52 Week Low
- MDGL $200.63
- TFX $119.08
- 52 Week High
- MDGL $377.46
- TFX $249.91
- Technical
- Relative Strength Index (RSI)
- MDGL 38.56
- TFX 40.16
- Support Level
- MDGL $265.39
- TFX $119.08
- Resistance Level
- MDGL $275.54
- TFX $123.33
- Average True Range (ATR)
- MDGL 11.39
- TFX 2.80
- MACD
- MDGL -1.08
- TFX -0.06
- Stochastic Oscillator
- MDGL 24.12
- TFX 14.58
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.